Abstract
Differential drug response in a human cell line panel representing defined types of cytotoxic drug resistance was measured using the non-clonogenic fluorometric microculture cytotoxicity assay (FMCA). In total 37 drugs were analysed; eight topoisomerase II inhibitors, eight anti-metabolites, eight alkylating agents, eight tubulin-active agents and five compounds with other or unknown mechanisms of action, including one topoisomerase I inhibitor. Correlation analysis of log IC50 values obtained from the panel showed a high degree of similarity among the drugs with a similar mechanism of action. The mean percentage of mechanistically similar drugs included among the ten highest correlations, when each drug was compared with the remaining data set, was 100%, 92%, 88% and 52% for the topoisomerase II inhibitors, alkylators, tubulinactive agents and anti-metabolites respectively. Classification of drugs into the four categories representing different mechanisms of action using a probabilistic neural network (PNN) analysis resulted in 29 (91%) correct predictions. The results indicate the feasibility of using a limited number of cell lines for prediction of mechanism of action of anti-cancer drugs. The present approach may be well suited for initial classification and evaluation of novel anti-cancer drugs and as a potential tool to guide lead compound optimisation.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dhar, S., Nygren, P., Csoka, K. et al. Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance. Br J Cancer 74, 888–896 (1996). https://doi.org/10.1038/bjc.1996.453
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.453
- Springer Nature Limited
This article is cited by
-
Machine Learning and Network Analyses Reveal Disease Subtypes of Pancreatic Cancer and their Molecular Characteristics
Scientific Reports (2020)
-
Gambogic acid is cytotoxic to cancer cells through inhibition of the ubiquitin-proteasome system
Investigational New Drugs (2013)
-
Brunn: An open source laboratory information system for microplates with a graphical plate layout design process
BMC Bioinformatics (2011)
-
Characterization of the cytotoxic activity of the indoloquinoline alkaloid cryptolepine in human tumour cell lines and primary cultures of tumour cells from patients
Investigational New Drugs (2009)
-
In vitro activity of bortezomib in cultures of patient tumour cells—potential utility in haematological malignancies
Medical Oncology (2009)